- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pulmonary Mucormycosis in Austria
Total 509 results
-
Aerami TherapeuticsCompletedPulmonary Arterial HypertensionAustralia
-
Bial - Portela C S.A.CompletedPulmonary Arterial HypertensionAustria, Germany, Italy, Portugal, Spain, United Kingdom
-
Bayside HealthUniversity of MelbourneCompletedCystic Fibrosis | Chronic Obstructive Pulmonary Disease (COPD)Australia
-
Apreo Health, Inc.RecruitingEmphysema or COPDUnited Kingdom, Austria, Netherlands
-
Syndax PharmaceuticalsDevPro BiopharmaRecruitingIdiopathic Pulmonary FibrosisAustralia
-
Medical University of ViennaCompletedHypertension, Pulmonary | Heart Failure With Normal Ejection FractionAustria
-
University Teaching Hospital Hall in TirolCompletedHypertension, Pulmonary | Heart Failure, DiastolicAustria
-
BayerCompletedHypertension, PulmonaryGermany, Czechia, Austria, Poland
-
ActelionCompletedPulmonary Arterial HypertensionCanada, United Kingdom, Italy, United States, Netherlands, Australia, Austria, Belgium, France, Germany, Spain
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Medical University of GrazEuropean Respiratory SocietyRecruitingPulmonary Circulation DiseasesUnited States, Italy, United Kingdom, Austria, Australia, Belgium, Brazil, Denmark, France, Germany, Netherlands, Poland, Spain, Switzerland
-
Respira Therapeutics, Inc.CompletedPulmonary Arterial HypertensionAustralia
-
Novartis PharmaceuticalsCompletedPulmonary Arterial HypertensionAustria, Germany, United States, United Kingdom
-
Medical University of ViennaRecruitingThrombosis | Pulmonary Embolism | EnoxaparinAustria
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Australia, Czech Republic, Poland
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary DiseaseGermany, Austria
-
Pulmonx CorporationActive, not recruitingPulmonary EmphysemaAustralia
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseNetherlands, Austria, Denmark, Norway, Sweden
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, United Kingdom, Poland, Netherlands
-
GlaxoSmithKlineCompleted
-
Medical University of GrazCompletedPulmonary Hypertension | Sjögren SyndromeAustria
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Hypertension, PulmonaryUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, Korea, Republic of, China, Australia
-
United TherapeuticsCompletedPulmonary Arterial Hypertension | Hypertension, PulmonaryUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)China, Australia, India
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)France, Belgium, Netherlands, Austria, Germany, United Kingdom
-
Neovii BiotechCompletedBronchiectasis | Idiopathic Pulmonary Fibrosis | Cystic Fibrosis | Chronic Obstructive Pulmonary | Pulmonary Vascular DiseaseUnited States, Australia, Austria, Canada
-
ActelionCompletedPulmonary HypertensionUnited States, Netherlands, Canada, Spain, China, Belgium, Germany, Italy, United Kingdom, Switzerland, Australia, Austria, Czech Republic, France
-
ResMedThe University of Western Australia; Sir Charles Gairdner HospitalTerminatedRespiratory Insufficiency | Chronic Obstructive Pulmonary Disease (COPD) | Obesity Hypoventilation Syndrome | Neuromuscular Disease | Upper Airway ObstructionAustralia
-
Isabelle Opitz, Professor, MDRecruitingSurgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema (SINCERE)EmphysemaBelgium, Switzerland, Denmark, Austria
-
Pulmonx International SàrlCompletedCOPD Patients With Homogeneous Emphysema | Endoscopic Lung Volume Reduction With Endobronchial ValveGermany, Austria, Netherlands
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedStudy in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Chronic Obstructive Pulmonary Disease (COPDUnited States, Australia, New Zealand
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
University of PecsCompleted
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
VenitiWithdrawnDeep Vein Thrombosis | Pulmonary EmbolusNew Zealand, Australia
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
Philips HealthcareCompletedSepsis | Renal Failure | Pulmonary Edema | Cardio-pulmonary ArrestAustralia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Medical University InnsbruckBoehringer IngelheimUnknownCovid-19 | Pulmonary FibrosisAustria
-
AOP Orphan Pharmaceuticals AGEnrolling by invitationPulmonary Arterial HypertensionFrance, Spain, Germany, Italy, Hungary, Austria, Czechia, Poland, Romania
-
Pharmosa Biopharm Inc.PPDCompletedPulmonary Arterial HypertensionUnited States
-
Celtaxsys, Inc.Linear Clinical Research; CPR Pharma Services Pty Ltd, Australia; Clinical Network...Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand